Krishna Institute of Medical Sciences Limited (KIMS.BO)
INR 588.6
(0.97%)
INR 588.6
(0.97%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 6.61 Billion INR | 1.67% |
| 2022 | 6.51 Billion INR | 15.46% |
| 2021 | 5.41 Billion INR | 42.2% |
| 2020 | 3.85 Billion INR | 49.65% |
| 2019 | 2.55 Billion INR | 30.84% |
| 2018 | 904.71 Million INR | 38.44% |
| 2017 | 1.06 Billion INR | 18.78% |
| 2016 | 1.2 Billion INR | 6.12% |
| 2015 | 1.13 Billion INR | 40.27% |
| 2014 | 800.45 Million INR | 97.19% |
| 2013 | 405.92 Million INR | -16.52% |
| 2012 | 637.81 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.79 Billion INR | 10.21% |
| 2023 Q4 | 1.58 Billion INR | 5.8% |
| 2023 FY | - INR | 1.67% |
| 2023 Q1 | 1.6 Billion INR | -4.72% |
| 2023 Q2 | 1.8 Billion INR | 12.46% |
| 2023 Q3 | 1.5 Billion INR | -16.59% |
| 2022 Q1 | 1.42 Billion INR | 10.29% |
| 2022 FY | - INR | 15.46% |
| 2022 Q4 | 1.68 Billion INR | 6.65% |
| 2022 Q3 | 1.57 Billion INR | -2.48% |
| 2022 Q2 | 1.61 Billion INR | 13.43% |
| 2021 Q2 | 1.34 Billion INR | -9.3% |
| 2021 Q3 | 1.34 Billion INR | -0.05% |
| 2021 Q4 | 1.29 Billion INR | -3.67% |
| 2021 Q1 | 1.47 Billion INR | 45.21% |
| 2021 FY | - INR | 42.2% |
| 2020 Q3 | 931.16 Million INR | -34.78% |
| 2020 Q1 | 400.86 Million INR | -34.88% |
| 2020 FY | - INR | 49.65% |
| 2020 Q4 | 1.01 Billion INR | 9.42% |
| 2020 Q2 | 1.42 Billion INR | 256.18% |
| 2019 FY | - INR | 30.84% |
| 2019 Q4 | 615.54 Million INR | 0.0% |
| 2018 FY | - INR | 38.44% |
| 2017 FY | - INR | 18.78% |
| 2017 Q2 | 312.69 Million INR | 0.0% |
| 2017 Q1 | 312.69 Million INR | 0.0% |
| 2016 FY | - INR | 6.12% |
| 2015 FY | - INR | 40.27% |
| 2014 FY | - INR | 97.19% |
| 2013 FY | - INR | -16.52% |
| 2012 FY | - INR | 0.0% |